Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -152,893 | -81,499 | -181,223 | -111,894 | -128,436 |
| Depreciation Amortization | 9,921 | 5,109 | 15,596 | 10,988 | 6,797 |
| Income taxes - deferred | N/A | N/A | -93,649 | -94,824 | N/A |
| Accounts receivable | -2,817 | -3,611 | -7,166 | -6,871 | -3,099 |
| Accounts payable and accrued liabilities | 1,331 | 6,373 | 6,363 | 196 | 1,403 |
| Other Working Capital | -33,707 | -24,765 | 20,327 | 9,841 | 4,853 |
| Other Operating Activity | 38,573 | 19,364 | 128,572 | 113,092 | 79,666 |
| Operating Cash Flow | $-139,592 | $-79,029 | $-111,180 | $-79,472 | $-38,816 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,571 | 45,691 | -352,807 | -421,402 | -450,668 |
| PPE Investments | -7,657 | -3,638 | -5,931 | -3,089 | -1,970 |
| Net Acquisitions | N/A | N/A | -319,793 | -319,793 | N/A |
| Investing Cash Flow | $-18,228 | $42,053 | $-678,531 | $-744,284 | $-452,638 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 895,536 | 895,536 | 895,536 |
| Debt Repayment | -770 | -377 | -361 | 0 | 0 |
| Common Stock Issued | 6,440 | 5,592 | 326,651 | 324,967 | 25,311 |
| Other Financing Activity | 0 | 0 | -52,245 | -52,246 | -52,246 |
| Financing Cash Flow | $5,670 | $5,215 | $1,169,581 | $1,168,257 | $868,601 |
| Beginning Cash Position | 465,817 | 465,817 | 85,947 | 85,947 | 85,947 |
| End Cash Position | 313,667 | 434,056 | 465,817 | 430,448 | 463,094 |
| Net Cash Flow | $-152,150 | $-31,761 | $379,870 | $344,501 | $377,147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -139,592 | -79,029 | -111,180 | -79,472 | -38,816 |
| Capital Expenditure | -7,657 | -3,638 | -5,931 | -3,089 | -1,970 |
| Free Cash Flow | -147,249 | -82,667 | -117,111 | -82,561 | -40,786 |